Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.

Andrade, Adriana; Rosenkranz, Susan L.; Cillo, Anthony R.; Lu, Darlene; Daar, Eric S.; Jacobson, Jeffrey M.; Lederman, Michael; Acosta, Edward P; Campbell, Thomas; Feinberg, Judith; Flexner, Charles; Mellors, John W.; Kuritzkes, Daniel R.

doi:10.1093/infdis/jit272

Record: found
Abstract: found
Article: not found

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.

Author(s): Adriana Andrade ¹ , Susan L Rosenkranz , Anthony R Cillo , Darlene Lu , Eric S Daar , Jeffrey M Jacobson , Michael Lederman , Edward P Acosta , Thomas Campbell , Judith Feinberg , Charles Flexner , John W Mellors , Daniel R Kuritzkes

Publication date (Electronic): Sep 2013

Journal: The Journal of infectious diseases

Keywords: ACTG A5160s, ACTG A5166s, ACTG A5248, Roche ultrasensitive assay, raltegravir, single copy assay, viral decay

Read this article at

ScienceOpenPublisher PMC

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The goal of this study was to define viral kinetics after initiation of raltegravir (RAL)-based antiretroviral therapy (ART).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Infect. Dis.

Title: The Journal of infectious diseases

ISSN (Electronic): 1537-6613

ISSN (Print): 0022-1899

Publication date (Electronic): Sep 2013

Volume: 208

Issue: 6

Affiliations

[1 ] The Johns Hopkins University, Baltimore, Maryland 21205, USA. aandrade@jhmi.edu

Article

Publisher Item ID: jit272

DOI: 10.1093/infdis/jit272

PMC ID: 3749011

PubMed ID: 23801609

SO-VID: 5da682aa-5140-4658-b963-f21e25a0eea7

History

Keywords: ACTG A5160s,ACTG A5166s,ACTG A5248,Roche ultrasensitive assay,raltegravir,single copy assay,viral decay

Data availability:

Keywords: ACTG A5160s, ACTG A5166s, ACTG A5248, Roche ultrasensitive assay, raltegravir, single copy assay, viral decay

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.

Read this article at

Abstract

Related collections

Recursive Rule based Visual Categorization

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 17